Insider Transactions in Q2 2025 at Vaxcyte, Inc. (PCVX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 12
2025
|
Olivier Brandicourt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,148
+50.0%
|
-
|
|
Jun 12
2025
|
Teri Loxam Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,041
+22.94%
|
-
|
|
Jun 12
2025
|
Halley E Gilbert Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,041
+22.94%
|
-
|
|
Jun 12
2025
|
Carlos V Paya Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,041
+39.85%
|
-
|
|
Jun 12
2025
|
Anne S Drapeau Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,041
+22.94%
|
-
|
|
Jun 12
2025
|
Jacks Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,041
+39.85%
|
-
|
|
Jun 12
2025
|
John Furey Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,041
+50.0%
|
-
|
|
Jun 12
2025
|
Heath Lukatch Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,041
+15.01%
|
-
|
|
Apr 08
2025
|
Heath Lukatch Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+18.94%
|
$126,000
$18.75 P/Share
|
|
Apr 07
2025
|
Andrew Guggenhime PRESIDENT AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,777
+3.49%
|
$95,540
$20.93 P/Share
|
|
Apr 04
2025
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
20,533
+1.94%
|
$266,929
$13.14 P/Share
|